AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2017

Jun 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2017-06-13

Reporting Person: MARAGANORE JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-13	Stock option (right to buy)	$50.73	A	8000	Acquired	2027-06-12	Common stock (8000)	Direct

Footnotes

F1: This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018.